Maximal cytoreductive effort in epithelial ovarian cancer surgery
Open Access
- 1 January 2010
- journal article
- Published by Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy in Journal of Gynecologic Oncology
- Vol. 21 (2), 75-80
- https://doi.org/10.3802/jgo.2010.21.2.75
Abstract
The surgical management of advanced epithelial ovarian cancer involves cytoreduction, or removal of grossly-evident tumor. Residual disease after surgical cytoreduction of ovarian cancer has been shown to be strongly associated with survival. The goal of surgery is "optimal" surgical cytoreduction, which is generally defined as residual disease of 1 cm or less. However, the designation of "optimal" surgical cytoreduction has evolved to include maximal surgical effort and no gross residual disease. In order to achieve this, more aggressive surgical procedures such as rectosigmoidectomy, diaphragm peritonectomy, partial liver resection, and video-assisted thoracic surgery are reported and increasingly utilized in the surgical management of advanced ovarian cancer. The role of maximal surgical effort also extends to the recurrent setting where the goal of surgery should be complete cytoreduction. Patient selection is important in identifying appropriate candidates for surgical cytoreduction in the recurrent setting. The purpose of this article is to review the role of maximum surgical effort in primary and recurrent ovarian cancer.Keywords
This publication has 61 references indexed in Scilit:
- The role of secondary cytoreduction in the treatment of ovarian cancer: Hacettepe University experienceAmerican Journal of Obstetrics and Gynecology, 2006
- Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel–platinumEuropean Journal of Surgical Oncology, 2005
- Secondary cytoreductive surgery for recurrent epithelial ovarian cancerPublished by Ovid Technologies (Wolters Kluwer Health) ,2002
- Secondary Cytoreductive Surgery for Patients with Recurrent Epithelial Ovarian CarcinomaGynecologic Oncology, 2001
- Secondary Cytoreductive Surgery for Localized Intra-abdominal Recurrences in Epithelial Ovarian CancerGynecologic Oncology, 2001
- Complete Salvage Surgical Cytoreduction Improves Further Survival of Patients with Late Recurrent Ovarian CancerGynecologic Oncology, 2000
- Secondary Cytoreductive Surgery at Second-Look Laparotomy in Advanced Ovarian Cancer: A Gynecologic Oncology Group StudyGynecologic Oncology, 1997
- Prognostic Significance of Residual Disease in Patients with Stage IV Epithelial Ovarian CancerGynecologic Oncology, 1997
- Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective studyCancer, 1995
- En bloc resection of epithelial ovarian tumors with concomitant rectosigmoid colectomy: the KEMH experienceInternational Journal of Gynecologic Cancer, 1993